Philip Jones

7.8k total citations
92 papers, 3.6k citations indexed

About

Philip Jones is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Philip Jones has authored 92 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 30 papers in Oncology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Philip Jones's work include Receptor Mechanisms and Signaling (22 papers), Histone Deacetylase Inhibitors Research (19 papers) and Protein Degradation and Inhibitors (19 papers). Philip Jones is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Histone Deacetylase Inhibitors Research (19 papers) and Protein Degradation and Inhibitors (19 papers). Philip Jones collaborates with scholars based in United States, Italy and United Kingdom. Philip Jones's co-authors include Christian Steinkühler, Michael Rowley, Raffaele De Francesco, Paola Gallinari, Andrea Carfı́, Carlo Toniatti, Petra Neddermann, Rita Scarpelli, Paola Lo Surdo and Matthew J. Bottomley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Philip Jones

91 papers receiving 3.5k citations

Peers

Philip Jones

ONCOL

CMN

PHARM

Sabrina Taliani Italy

Guangrong Zheng United States

Simona Daniele Italy

Russell Dahl United States

Chikara Murakata Japan

Scott D. Kuduk United States

Carlos Davio Argentina

Rajendra K. Sharma Canada

Misty M. Attwood Sweden

Shouki Kassis United States

Sabrina Taliani Italy

Philip Jones

1.8k ×0.7

622 ×0.6

ONCOL

490 ×0.8

CMN

1.2k ×2.3

268 ×0.9

PHARM

Citations per year, relative to Philip Jones Philip Jones (= 1×) peers Sabrina Taliani

Countries citing papers authored by Philip Jones

Since Specialization

Citations

This map shows the geographic impact of Philip Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Jones more than expected).

Fields of papers citing papers by Philip Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Jones. The network helps show where Philip Jones may publish in the future.

Co-authorship network of co-authors of Philip Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Jones. A scholar is included among the top collaborators of Philip Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Jones. Philip Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hao, Xiaoxin, Na Zhao, Diego A. Pedroza, et al.. (2024). CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 9(20). 3 indexed citations

Dedic, Nina, Lien Wang, Éva Hajós‐Korcsok, et al.. (2024). TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding. Molecular Metabolism. 80. 101883–101883. 11 indexed citations

Liu, Arthur, Jeffrey J. Molldrem, Gheath Alatrash, et al.. (2024). Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia. Cancer Research Communications. 4(3). 911–918. 1 indexed citations

Dedic, Nina, Philip Jones, Éva Hajós‐Korcsok, et al.. (2023). TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain. CNS Spectrums. 28(2). 259–259. 1 indexed citations

Sorokin, Alexey V., Preeti Kanikarla Marie, Ganiraju C. Manyam, et al.. (2022). Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Research. 82(18). 3335–3344. 37 indexed citations

Zhao, Na, Reid T. Powell, Kevin Roarty, et al.. (2021). Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nature Communications. 12(1). 4262–4262. 43 indexed citations

Ferrigno, Federica, Danila Branca, Olaf Kinzel, et al.. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters. 20(3). 1100–1105. 14 indexed citations

Pescatore, Giovanna, Danila Branca, Olaf Kinzel, et al.. (2009). Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 20(3). 1094–1099. 17 indexed citations

Wang, Yuren, Pranab K. Chanda, Philip Jones, & Jeffrey D. Kennedy. (2008). A Fluorescence-Based Assay for Monoacylglycerol Lipase Compatible with Inhibitor Screening. Assay and Drug Development Technologies. 6(3). 387–393. 23 indexed citations

10.

Scarpelli, Rita, Annalise Di Marco, Federica Ferrigno, et al.. (2008). Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(23). 6078–6082. 17 indexed citations

11.

Naureckiene, Saule, Sreekumar Kodangattil, Edward Kaftan, et al.. (2008). Identification of Critical Amino Acid Residues for Human iNOS Functional Activity. The Protein Journal. 27(5). 309–318. 6 indexed citations

12.

Gallo, Pasquale, Michael V.G. Latronico, Paolo Gallo, et al.. (2008). Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovascular Research. 80(3). 416–424. 135 indexed citations

13.

Lahm, Armin, Chantal Paolini, Michele Pallaoro, et al.. (2007). Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proceedings of the National Academy of Sciences. 104(44). 17335–17340. 443 indexed citations

14.

Bingham, Brendan, et al.. (2007). Species‐specificin vitropharmacological effects of the cannabinoid receptor 2 (CB₂) selective ligand AM1241 and its resolved enantiomers. British Journal of Pharmacology. 151(7). 1061–1070. 78 indexed citations

15.

Wang, Yuren, Jun Xu, Albert J. Uveges, et al.. (2006). A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening. Analytical Biochemistry. 354(1). 35–42. 6 indexed citations

16.

Wang, Yuren, Girija Krishnamurthy, A. Gilbert, et al.. (2006). High-Throughput Screening for the Discovery of Inhibitors of Fatty Acid Amide Hydrolase Using a Microsome-Based Fluorescent Assay. SLAS DISCOVERY. 11(5). 519–527. 9 indexed citations

17.

Jones, Philip, Sergio Altamura, Prasun K. Chakravarty, et al.. (2006). A series of novel, potent, and selective histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(23). 5948–5952. 52 indexed citations

18.

Liang, Jinjun, Hui Chen, Philip Jones, & Xavier Khawaja. (2000). RGS7 complex formation and colocalization with the G?5 subunit in the adult rat brain and influence on G?5?2-mediated PLC? signaling. Journal of Neuroscience Research. 60(1). 58–64. 26 indexed citations

19.

Truong, Amy, et al.. (1999). Probing the Potassium Channel K_vβ1/K_v1.1 Interaction Using a Random Peptide Display Library. Annals of the New York Academy of Sciences. 868(1). 427–430. 2 indexed citations

20.

Jones, Philip, et al.. (1998). Cloning and tissue distribution of the human G protein β5 cDNA. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1402(3). 288–291. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact